AG23041
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AG23041, covering 2025-04-08 to 2025-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042 [Phase 1]